The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tullman Stephen A. since 2018.
The trader's CIK number is 1654343.
At the time of the last reporting, Tullman Stephen A. was the Director of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS).
Also see all insider trading activities at Aclaris Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ACRS | 46,650 | $739,787 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-04 | ACRS | Buy | 7,100 | 14.00 | 99,371 |
| 2018-08-23 | ACRS | Buy | 6,600 | 15.00 | 98,986 |
| 2018-08-15 | ACRS | Buy | 6,250 | 15.97 | 99,812 |
| 2018-04-06 | ACRS | Buy | 26,700 | 16.54 | 441,618 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tullman Stephen A. (Director of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.